Literature DB >> 9751507

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

G G Kuiper1, J G Lemmen, B Carlsson, J C Corton, S H Safe, P T van der Saag, B van der Burg, J A Gustafsson.   

Abstract

The rat, mouse and human estrogen receptor (ER) exists as two subtypes, ER alpha and ER beta, which differ in the C-terminal ligand-binding domain and in the N-terminal transactivation domain. In this study, we investigated the estrogenic activity of environmental chemicals and phytoestrogens in competition binding assays with ER alpha or ER beta protein, and in a transient gene expression assay using cells in which an acute estrogenic response is created by cotransfecting cultures with recombinant human ER alpha or ER beta complementary DNA (cDNA) in the presence of an estrogen-dependent reporter plasmid. Saturation ligand-binding analysis of human ER alpha and ER beta protein revealed a single binding component for [3H]-17beta-estradiol (E2) with high affinity [dissociation constant (Kd) = 0.05 - 0.1 nM]. All environmental estrogenic chemicals [polychlorinated hydroxybiphenyls, dichlorodiphenyltrichloroethane (DDT) and derivatives, alkylphenols, bisphenol A, methoxychlor and chlordecone] compete with E2 for binding to both ER subtypes with a similar preference and degree. In most instances the relative binding affinities (RBA) are at least 1000-fold lower than that of E2. Some phytoestrogens such as coumestrol, genistein, apigenin, naringenin, and kaempferol compete stronger with E2 for binding to ER beta than to ER alpha. Estrogenic chemicals, as for instance nonylphenol, bisphenol A, o, p'-DDT and 2',4',6'-trichloro-4-biphenylol stimulate the transcriptional activity of ER alpha and ER beta at concentrations of 100-1000 nM. Phytoestrogens, including genistein, coumestrol and zearalenone stimulate the transcriptional activity of both ER subtypes at concentrations of 1-10 nM. The ranking of the estrogenic potency of phytoestrogens for both ER subtypes in the transactivation assay is different; that is, E2 >> zearalenone = coumestrol > genistein > daidzein > apigenin = phloretin > biochanin A = kaempferol = naringenin > formononetin = ipriflavone = quercetin = chrysin for ER alpha and E2 >> genistein = coumestrol > zearalenone > daidzein > biochanin A = apigenin = kaempferol = naringenin > phloretin = quercetin = ipriflavone = formononetin = chrysin for ER beta. Antiestrogenic activity of the phytoestrogens could not be detected, except for zearalenone which is a full agonist for ER alpha and a mixed agonist-antagonist for ER beta. In summary, while the estrogenic potency of industrial-derived estrogenic chemicals is very limited, the estrogenic potency of phytoestrogens is significant, especially for ER beta, and they may trigger many of the biological responses that are evoked by the physiological estrogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751507     DOI: 10.1210/endo.139.10.6216

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  884 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 3.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 4.  Estrogen receptors: orchestrators of pleiotropic cellular responses.

Authors:  J G Moggs; G Orphanides
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

5.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

6.  Occupational pesticide exposure and subclinical hypothyroidism among male pesticide applicators.

Authors:  Catherine C Lerro; Laura E Beane Freeman; Curt T DellaValle; Muhammad G Kibriya; Briseis Aschebrook-Kilfoy; Farzana Jasmine; Stella Koutros; Christine G Parks; Dale P Sandler; Michael C R Alavanja; Jonathan N Hofmann; Mary H Ward
Journal:  Occup Environ Med       Date:  2017-08-03       Impact factor: 4.402

7.  Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial.

Authors:  V W Henderson; J A St John; H N Hodis; N Kono; C A McCleary; A A Franke; W J Mack
Journal:  Neurology       Date:  2012-06-05       Impact factor: 9.910

Review 8.  Of mice and rats: key species variations in the sexual differentiation of brain and behavior.

Authors:  P J Bonthuis; K H Cox; B T Searcy; P Kumar; S Tobet; E F Rissman
Journal:  Front Neuroendocrinol       Date:  2010-05-10       Impact factor: 8.606

9.  Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach.

Authors:  Samir Satih; Nasséra Chalabi; Nadège Rabiau; Rémy Bosviel; Luc Fontana; Yves-Jean Bignon; Dominique J Bernard-Gallon
Journal:  OMICS       Date:  2010-06

10.  Anatomical specificity of the brain in the modulation of Neuroglobin and Cytoglobin genes after chronic bisphenol a exposure.

Authors:  Rodrigo Rodrigues da Conceição; Janaina Sena de Souza; Kelen Carneiro de Oliveira; Rui Monteiro de Barros Maciel; Marco Aurélio Romano; Renata Marino Romano; Magnus Régios Dias da Silva; Maria Izabel Chiamolera; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2017-07-18       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.